Jackson, Grant Investment Advisers, Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
Jackson, Grant Investment Advisers, Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$29,960
-16.9%
5000.0%0.01%
-17.6%
Q2 2023$36,050
-2.0%
5000.0%0.02%0.0%
Q1 2023$36,780
+10.1%
5000.0%0.02%
+6.2%
Q4 2022$33,400
-22.3%
5000.0%0.02%
-27.3%
Q3 2022$43,000
-4.4%
5000.0%0.02%0.0%
Q2 2022$45,000
-19.6%
5000.0%0.02%
-8.3%
Q1 2022$56,000
-27.3%
5000.0%0.02%
-38.5%
Q4 2021$77,000
+10.0%
5000.0%0.04%
+25.8%
Q3 2021$70,000
+6.1%
5000.0%0.03%
+6.9%
Q2 2021$66,000
-13.2%
5000.0%0.03%
-17.1%
Q1 2021$76,000
+52.0%
5000.0%0.04%
+34.6%
Q4 2020$50,000
+4.2%
5000.0%0.03%
-10.3%
Q3 2020$48,000
-14.3%
5000.0%0.03%
-19.4%
Q2 2020$56,000
+55.6%
5000.0%0.04%
+33.3%
Q1 2020$36,000
-30.8%
5000.0%0.03%
-3.6%
Q4 2019$52,000
+4.0%
5000.0%0.03%0.0%
Q3 2019$50,000
-12.3%
5000.0%0.03%
-15.2%
Q2 2019$57,000
-9.5%
5000.0%0.03%
-13.2%
Q1 2019$63,000
-7.4%
5000.0%0.04%
-20.8%
Q4 2018$68,000
-50.4%
5000.0%0.05%
-44.2%
Q3 2018$137,0005000.09%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders